http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
S. P. Goyal,R. Mukherjee,R. Jain 경북대학교 자연과학대학 수학과 2004 Kyungpook mathematical journal Vol.44 No.4
In the present paper, we establish a general theorem exhibiting a relationship existing between the Laplace transform and the generalized Weyl fractional integral operator (FIO) of related functions. This theorem is very general in nature and involves a multidimensional series with essentially arbitrary sequence of complex numbers. By suitably assigning different values to these sequences, one can easily evaluate the generalized Weyl fractional integral operator of special functions of several variables. References of known results which follow as special cases of our theorem are also cited. We have obtained here as applications of the theorem, the generalized Weyl fractional integral of(Srivastava-Daoust) generalized Lauricella function which gives a number of results involving special functions of one or more variables merely by specializing the parameters. The results recently obtained by R. Jain and M. A. Pathan and S. P. Goyal and Ritu Goyal,etc. follow as special cases of our main findings.
Alex Barnes,Jane M Andrews,Sutapa Mukherjee,Robert V Bryant,Peter Bampton,Robert J. Fraser,Réme Mountifield 대한장연구학회 2024 Intestinal Research Vol.22 No.1
Background/Aims: Insomnia is common in people with chronic medical conditions, such as inflammatory bowel disease (IBD), and is readily treatable through cognitive behavioral therapy for insomnia. This study aimed to describe the associations with insomnia in people with IBD and its relationship to IBD-related disability.Methods: An online questionnaire was administered through 3 tertiary IBD centers, social media, and Crohn’s Colitis Australia. The questionnaire included the Insomnia Severity Index (ISI), a validated assessment of insomnia. Measures of anxiety, depression, physical activity, and disability were also included. IBD activity was assessed using validated patient reported scores. A multivariate model was constructed for clinically significant insomnia and ISI scores. Subpopulations of Crohn’s disease and ulcerative colitis were considered.Results: In a cohort of 670 respondents the median age was 41 years (range, 32–70 years), with the majority female (78.4%), the majority had Crohn’s disease (57.3%). Increasingly severe disability was associated with worse insomnia score. Clinically significant insomnia was associated with clinically active IBD, abdominal pain, anxiety, and depression, in a multivariate model. In an ulcerative colitis population, Simple Clinical Colitis Activity Index components of general well-being and urgency were associated with worse ISI score in a model including depression and anxiety. In those with Crohn’s disease, the multivariate model included Harvey Bradshaw Index score in addition to depression and anxiety.Conclusions: Insomnia is common in people with IBD and is associated with increased disability. Abdominal pain and mental health conditions should prompt consideration for screening for insomnia and referral for cognitive behavioral therapy for insomnia.
Mukherjee, R,Kim, S W,Park, T,Choi, M S,Yun, J W Nature Publishing Group 2015 International Journal of Obesity Vol.39 No.9
Background:Galectin 1 (GAL1), an animal lectin is well characterized in the context of cancer, tumor environment, but its physiological roles in obesity remain to be demonstrated. In this study, we investigated whether targeted inhibition of GAL1 prevents obesity based on the previous observations that GAL1 is highly expressed in adipose tissues of high-fat diet (HFD)-induced obese rats.Methods:Lipogenic capacity of Lgals1 knocked down adipocytes was evaluated by determining the expression levels of major lipogenic markers using real-time PCR and immunoblot analysis. GAL1 partner proteins were identified using co-immunoprecipitation followed by protein mass fingerprinting. Finally, inhibitory effect of GAL1 by thiodigalactoside (TDG) was assessed in adipocytes and HFD-induced obese rats.Results:Knockdown of GAL1-encoding gene (Lgals1) attenuated adipogenesis and lipogenesis in both 3T3-L1 and HIB1B adipocytes. Further, direct treatment with TDG, a potent inhibitor of GAL1, to cultured adipocytes in vitro significantly reduced fat accumulation. Our animal experiment revealed that intraperitoneal injection of TDG (5 mg kg<SUP>−1</SUP>) once per week for 5 weeks in Sprague-Dawley (SD) rats resulted in dramatic inhibition of HFD-induced body weight gain (27.3% reduction compared with HFD-fed controls) by inhibiting adipogenesis and lipogensis as well as by increasing expression of the proteins associated with thermogenesis and energy expenditure.Conclusion:GAL1 has an essential role in HFD-induced obesity development. From a clinical viewpoint, pharmaceutical targeting of GAL1 using TDG and other inhibitor compounds would be a novel therapeutic approach for the treatment of obesity.
Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1
Sharma, R.,Sharma, R.,Khaket, T. P.,Dutta, C.,Chakraborty, B.,Mukherjee, T. K. Springer Science + Business Media 2017 CELLULAR ONCOLOGY Vol.40 No.3
<P>Conclusions This study focuses on recent progress on the role of VCAM-1, an important glycoprotein belonging to the immunoglobulin (Ig) superfamily of cell surface adhesion molecules in breast cancer angiogenesis, survival and metastasis. Targeting VCAM-1, expressed on the surface of breast cancer cells, and/or its specific ligand VLA-4/alpha 4 beta 1 integrin, expressed on cells at the site of metastasis, may be a useful strategy to reduce breast cancer cell invasion and metastasis. Various approaches to therapeutically target VCAM-1 and VLA-4 are also discussed.</P>